| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/26/1997 | EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies |
| 02/26/1997 | EP0759088A1 L-ascorbic acid production in microorganisms |
| 02/26/1997 | EP0759086A1 Method of introducing pathogen resistance in plants |
| 02/26/1997 | EP0759084A1 Complex inducible promoter system derivable from a phage of a lactic acid bacterium (lab), and its use in a lab for production of a desired protein |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759081A1 Glucan-binding proteins, and use thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759078A1 Genes for the synthesis of antipathogenic substances |
| 02/26/1997 | EP0759077A1 Lanthionine-containing antimicrobial compound |
| 02/26/1997 | EP0759075A1 Apoptosis regulating gene |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759066A1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof |
| 02/26/1997 | EP0656059A4 Purified chitinases and use thereof. |
| 02/26/1997 | EP0618769B1 Fungistatic method and composition employing type ii endoglycosidases and peroxidases |
| 02/26/1997 | EP0563346B1 Method for the production of carboxilic acid using microrganisms |
| 02/26/1997 | EP0437537B1 Bacterial detection by phage transduction of detectable phenotype |
| 02/26/1997 | EP0426768B1 Expression of a DNA sequence derived from a Nocardioform microorganism and encoding a cholesterol oxidase in a host Streptomyces microorganism |
| 02/26/1997 | CN1143967A Method for variation of chromatin condensation |
| 02/26/1997 | CN1143965A Carbocyclic compound |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1034129C Process for biological production of organic acids |
| 02/26/1997 | CA2184019A1 Insecticidal matrix and process for preparation thereof |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5606042 Dna sequence |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |
| 02/25/1997 | US5606022 Cloning and identification of a two component signal transducing regulatory system from Bacteroides fragilis |
| 02/25/1997 | US5606021 Mineralocorticoid receptor compositions and methods |
| 02/25/1997 | US5605886 Anti-obesity proteins |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605818 From culture medium containing corynebacterium or brevibacterium |
| 02/25/1997 | US5605817 DNA encoding chemokine expressed in fetal spleen |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605804 Monitoring course of disease in patient by performing series of immunoassays over time to determine changes in level of nonspecific crosssreacting antigen 50/90 in blood samples |
| 02/25/1997 | US5605803 Human sperm diagnostic |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605692 Polypeptide |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/23/1997 | CA2183606A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/20/1997 | WO1997006435A1 Improvements in or relating to methods of screening substances |
| 02/20/1997 | WO1997006277A1 Methods for drug screening |
| 02/20/1997 | WO1997006275A1 Process for producing optically active 2-alkoxycyclohexanol derivatives |
| 02/20/1997 | WO1997006271A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 02/20/1997 | WO1997006268A2 Dna constructs |
| 02/20/1997 | WO1997006261A2 THE USE OF HOMOLOGOUS amdS GENES AS SELECTABLE MARKERS |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006248A1 Processes for the production of amidase |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997006181A1 Production of xylanase and cellulase in b. subtilis |
| 02/20/1997 | WO1997006128A1 Selective process for the deacylation of acylated compounds |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2227445A1 Dna constructs |
| 02/20/1997 | CA2225680A1 Improvements in or relating to methods of screening substances |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758655A1 Process for the inactivation of carboxypeptidase Y in hirudin-containing culture broth |
| 02/19/1997 | EP0758398A1 Process for the biotransformation of carboxylic acids in the presence of a micro-organism |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/19/1997 | EP0758396A1 Feline immunodeficiency virus vaccine |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| 02/19/1997 | EP0758391A1 METALLOPROTEASES FROM $i(FUSARIUM) AND $i(ASPERGILLUS) HAVING THERMOLYSIN-LIKE ACTIVITY |
| 02/19/1997 | EP0758389A1 Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758385A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758381A1 Biologically active eph family ligands |
| 02/19/1997 | EP0758379A1 Use of a thermostable enzyme as a feed additive |
| 02/19/1997 | EP0758378A1 Thermostable xylanases |
| 02/19/1997 | EP0758373A1 Fabric cleaning compositions containing subtilisin bpn' variants |
| 02/19/1997 | CN1143388A Novel process for isolation of clavulanic acid and of pharmaceutically acceptable salts |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143325A Method for selective methionine starvation of malignant cells in mammals |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/19/1997 | CN1034086C Heteropolysaccharide S-657 |
| 02/19/1997 | CN1034084C Compact detergent composition with high activity cellulase |
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/19/1997 | CA2183196A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604129 Thermophilic fungal expression system |
| 02/18/1997 | US5604120 Hydrolysis in presence of lipase |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604111 Conversion of oxalate to formate and carbon dioxide in presence of formyl-coa transferase together with oxalyl-coa decarboxylase |
| 02/18/1997 | US5604102 Detecting and monitoring a terminal fragment of the beta-amyloid precursor protein produced by beta-secretase cleavage; alzheimer's disease |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5603930 Lactobacillus johnsonii CNCM I-1225 |
| 02/13/1997 | WO1997005488A1 Herpes simplex virus diagnostics |
| 02/13/1997 | WO1997005271A1 Production of microbial cellulose using a rotating disk film bioreactor |
| 02/13/1997 | WO1997005270A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | WO1997005269A1 Process for the preparation of lovastatin |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005254A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |